VYNE
Vyne Therapeutics Inc
NASDAQ: VYNE · HEALTHCARE · BIOTECHNOLOGY
$0.67
+0.53% today
Updated 2026-05-06
Market cap
$21.39M
P/E ratio
—
P/S ratio
37.52x
EPS (TTM)
$-0.63
Dividend yield
—
52W range
$0 – $2
Volume
0.2M
Vyne Therapeutics Inc (VYNE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+47.7%
Last 4 quarters
Revenue YoY growth
+54.8%
Most recent quarter
EPS YoY growth
+57.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.1%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+4.3%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-27 | $-0.12 | +61.3% | $0.59 | $0.61 | +1.9% |
| 2025-11-06 | $-0.17 | +43.3% | $0.34 | $0.35 | +4.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.31 | $-0.12 | +61.3% | $130000.00 | +54.8% |
| 2025-09-30 | $-0.30 | $-0.17 | +43.3% | $169000.00 | +39.7% |
| 2025-06-30 | $-0.29 | $-0.13 | +55.2% | $69000.00 | -65.2% |
| 2025-03-31 | $-0.29 | $-0.20 | +31.0% | $202000.00 | +106.1% |
| 2024-12-31 | $-0.30 | $-0.28 | +7.0% | $84000.00 | +10.5% |
| 2024-09-30 | $-0.23 | $-0.29 | -26.1% | $121000.00 | +6.1% |
| 2024-06-30 | $-0.19 | $-0.22 | -15.8% | $198000.00 | +46.7% |
| 2024-03-31 | $-0.24 | $-0.15 | +37.5% | $98000.00 | -1.0% |
| 2023-12-31 | $-0.50 | $-0.20 | +60.0% | $76000.00 | — |
| 2023-09-30 | $-0.76 | $-2.01 | -164.5% | $114000.00 | — |
| 2023-06-30 | $-1.99 | $-3.09 | -55.3% | $135000.00 | — |
| 2023-03-31 | $-2.61 | $-1.74 | +33.3% | $99000.00 | — |
Frequently asked questions
Has Vyne Therapeutics Inc beaten earnings estimates?
Vyne Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +47.7% over the last 4 quarters.
How does VYNE stock react to earnings?
VYNE stock has moved an average of +3.1% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Vyne Therapeutics Inc's revenue growth rate?
Vyne Therapeutics Inc reported year-over-year revenue growth of +54.8% in its most recent quarter, with EPS growing +57.5% year-over-year.